Edition:
United States

Ion Beam Applications SA (IBAB.BR)

IBAB.BR on Brussels Stock Exchange

52.06EUR
21 Apr 2017
Change (% chg)

€-0.09 (-0.17%)
Prev Close
€52.15
Open
€52.20
Day's High
€52.56
Day's Low
€51.79
Volume
32,036
Avg. Vol
47,662
52-wk High
€53.17
52-wk Low
€35.21

IBAB.BR

Chart for IBAB.BR

About

Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business... (more)

Overall

Beta: 0.84
Market Cap(Mil.): €1,549.53
Shares Outstanding(Mil.): 29.76
Dividend: 0.29
Yield (%): 1.95

Financials

  IBAB.BR Industry Sector
P/E (TTM): 61.28 49.60 29.95
EPS (TTM): 0.85 -- --
ROI: 12.79 6.66 13.21
ROE: 15.63 10.59 14.38

BRIEF-IBA FY REBITDA up 26.6 pct at 42.7 mln euros

* Reports FY revenue 328.8 million euros ($354.8 million) versus 270.4 million euros a year ago

Mar 23 2017

Rescued Azeri bank IBA not seen ready for privatisation yet

BAKU, March 17 State-owned International Bank of Azerbaijan (IBA) will need more government aid to clean up its balance sheet and is unlikely to be privatised as envisaged under a 2015 rescue plan for at least two years, an official and experts said.

Mar 17 2017

BRIEF-Ion Beam to install Spain's first proton therapy center

* Announces that it has signed a contract with Quirónsalud, Spain's leading hospital group and part of Germany's Helios Group, to install a Proteus(®)ONE compact proton therapy solution in Madrid

Feb 23 2017

BRIEF-IBA selected to install new proton therapy center in Charleroi, Belgium

* IBA selected to install new proton therapy center in Charleroi, Belgium

Feb 20 2017

IBA lowers operating margin guidance on weak dosimetry markets

BRUSSELS, Nov 16 Belgium's IBA, which makes proton therapy machines to treat cancer, slightly cut its margin expectations on Wednesday, due to weakness in its business measuring out doses of radiation.

Nov 16 2016

BRIEF-IBA Q3 YTD revenue up 19.3 pct at 225.3 mln euros

* Says Q3 2016 year to date group revenues of 225.3 million euros ($242.2 million), up 19.3 pct year-on-year

Nov 16 2016

More From Around the Web

Earnings vs. Estimates